Abstract
Beginning with the concept of the brain–gut axis, the importance of the interaction between the brain and the gastrointestinal tract has been extended to the microbiome with increasing clinical applications. With the recent development of various techniques for microbiome analysis, the number of relevant preclinical and clinical studies on animals and human subjects has rapidly increased. Various psychotic symptoms affect the intestinal microbiome through the hypothalamus–pituitary–adrenal gland axis. Conversely, the intestinal microbiome regulates the gastrointestinal tract environment and affects psychological factors by means of the microorganisms or their metabolites, either acting directly on the brain or through the synthesis of various neurotransmitters. This review discusses the clinical applicability of the brain–gut–microbiome axis and directions for improving psychological symptoms based on the studies published to date.
| Original language | English |
|---|---|
| Article number | 7122 |
| Pages (from-to) | 1-17 |
| Number of pages | 17 |
| Journal | International Journal of Molecular Sciences |
| Volume | 21 |
| Issue number | 19 |
| DOIs | |
| State | Published - 1 Oct 2020 |
Bibliographical note
Publisher Copyright:© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Keywords
- Brain–gut axis
- Microbiome
- Neurotransmitters
- Psychiatry
Fingerprint
Dive into the research topics of 'The brain–gut–microbiome axis in psychiatry'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver